Lora Kahn1, Nnenna Mbabuike1, Edison P Valle-Giler2, Juanita Garces2, R Clifton Moore3, Hugo St Hilaire4, Cuong J Bui1. 1. Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, LA. 2. Department of Neurosurgery, Ochsner Clinic Foundation, New Orleans, LA ; Department of Neurosurgery, Tulane Medical Center, New Orleans, LA. 3. Department of Maternal Fetal Medicine, Ochsner Clinic Foundation, New Orleans, LA ; The University of Queensland School of Medicine, Ochsner Clinical School, New Orleans, LA. 4. Department of Plastic and Reconstructive Surgery, Children's Hospital, New Orleans, LA, and Department of Plastic and Reconstructive Surgery, Louisiana State University Health Sciences Center, New Orleans, LA.
Abstract
BACKGROUND: Myelomeningocele is the most common form of congenital central nervous system defect that is compatible with life. Most patients with myelomeningocele have significant functional impairment of ambulation and bowel and bladder function, require permanent cerebrospinal fluid diversion with shunting, and have significant morbidity and mortality from hindbrain herniation (Chiari II malformation). The advent of intrauterine surgery has provided new opportunities to better address this lifelong debilitating disease. CASE REPORT: The patient was a 19-year-old gravida 2 para 1 at 22-6/7 weeks whose fetus was diagnosed with an open neural tube defect and further demonstrated to have ventriculomegaly and hindbrain herniation. Amniocentesis confirmed normal karyotype and the presence of acetylcholinesterase. After an intrauterine procedure, the patient underwent cesarean section at 35-5/7 weeks and delivered a male infant. His spinal incision was well healed at birth without any evidence of cerebrospinal fluid leakage, and his extremities were normal in appearance, range of motion, and movement. The infant also has maintained relatively normal, age-appropriate bowel and bladder function and has no obvious neurologic deficit. CONCLUSION: As the benefit of fetal surgery becomes more widely accepted, quality of care and patient safety must be at the forefront of any institution's effort to offer fetal surgery. Given the current prevalence of spina bifida and the amount of resources required to treat this disease effectively either in utero or postnatally, it is our opinion that the treatment of spina bifida should be regionalized to tertiary referral centers with the interdisciplinary expertise to offer comprehensive treatment for all aspects of the disease and all phases of care for the patients.
BACKGROUND: Myelomeningocele is the most common form of congenital central nervous system defect that is compatible with life. Most patients with myelomeningocele have significant functional impairment of ambulation and bowel and bladder function, require permanent cerebrospinal fluid diversion with shunting, and have significant morbidity and mortality from hindbrain herniation (Chiari II malformation). The advent of intrauterine surgery has provided new opportunities to better address this lifelong debilitating disease. CASE REPORT: The patient was a 19-year-old gravida 2 para 1 at 22-6/7 weeks whose fetus was diagnosed with an open neural tube defect and further demonstrated to have ventriculomegaly and hindbrain herniation. Amniocentesis confirmed normal karyotype and the presence of acetylcholinesterase. After an intrauterine procedure, the patient underwent cesarean section at 35-5/7 weeks and delivered a male infant. His spinal incision was well healed at birth without any evidence of cerebrospinal fluid leakage, and his extremities were normal in appearance, range of motion, and movement. The infant also has maintained relatively normal, age-appropriate bowel and bladder function and has no obvious neurologic deficit. CONCLUSION: As the benefit of fetal surgery becomes more widely accepted, quality of care and patient safety must be at the forefront of any institution's effort to offer fetal surgery. Given the current prevalence of spina bifida and the amount of resources required to treat this disease effectively either in utero or postnatally, it is our opinion that the treatment of spina bifida should be regionalized to tertiary referral centers with the interdisciplinary expertise to offer comprehensive treatment for all aspects of the disease and all phases of care for the patients.
Authors: M R Harrison; N S Adzick; M T Longaker; J D Goldberg; M A Rosen; R A Filly; M I Evans; M S Golbus Journal: N Engl J Med Date: 1990-05-31 Impact factor: 91.245
Authors: J P Bruner; N Tulipan; R L Paschall; F H Boehm; W F Walsh; S R Silva; M Hernanz-Schulman; L H Lowe; G W Reed Journal: JAMA Date: 1999-11-17 Impact factor: 56.272
Authors: M Meuli; C Meuli-Simmen; G M Hutchins; C D Yingling; K M Hoffman; M R Harrison; N S Adzick Journal: Nat Med Date: 1995-04 Impact factor: 53.440
Authors: N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer Journal: N Engl J Med Date: 2011-02-09 Impact factor: 91.245
Authors: Adibah Sahmat; Renuka Gunasekaran; Siti W Mohd-Zin; Lohis Balachandran; Meow-Keong Thong; Julia P Engkasan; Dharmendra Ganesan; Zaliha Omar; Abu Bakar Azizi; Azlina Ahmad-Annuar; Noraishah M Abdul-Aziz Journal: Front Pediatr Date: 2017-11-09 Impact factor: 3.418